Korlym

Active Ingredient(s): Mifepristone
FDA Approved: * February 17, 2012
Pharm Company: * CORCEPT THERAPEUTICS
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Korlym Overview

Mifepristone, also known as RU-486, is a medication typically used with misoprostol to bring about an abortion.[1] This combination is more than 95% effective during the first 50 days of pregnancy. It is also effective in the second trimester of pregnancy.[2][3] Two weeks after use effectiveness should be verified. It is taken by mouth.[1] Common side effects include abdominal pain, feeling tired, and vaginal bleeding. Serious side effects may include heavy vaginal bleeding, bacterial infecti...

Read more Korlym Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mifepristone

Recent Korlym Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Mifepristone
  • Tablet: 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Korlym: (1 result)

Sorted by National Drug Code
  • 76346-073 Korlym 300 mg Oral Tablet by Corcept Therapeutics Inc

Other drugs which contain Mifepristone or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 23 June 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.